Search

Author/Creator Gardiner, S

1. DOP61 Impact of prior tumour necrosis factor inhibitor failure and prior corticosteroid use on the maintenance of efficacy of tofacitinib following dose reduction in patients with Ulcerative Colitis who were in stable remission: 6-month data from the double-blind, randomised RIVETING study. (27th May 2021)

Authors:
Sandborn, W J; Dubinsky, M C; Torres, J; Vermeire, S; Kotze, P G; Su, C; Lawendy, N; Paulissen, J; Mundayat, R; Gardiner, S; Kulisek, N; Modesto, I; D'Haens, G R
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S096
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Low-energy physics in neutrino LArTPCs. (14th February 2023)

Authors:
Andringa, S; Asaadi, J; Bezerra, J T C; Capozzi, F; Caratelli, D; Cavanna, F; Church, E; Efremenko, Y; Foreman, W; Friedland, A; Gardiner, S; Gil-Botella, I; Himmel, A; Junk, T; Karagiorgi, G; Kirby, M; Klein, J; Lehmann-Miotto, G; Lepetic, I T; Li, S
Journal:
Journal of physics
Issue:
Volume 50:Number 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. New high-sensitivity searches for neutrons converting into antineutrons and/or sterile neutrons at the HIBEAM/NNBAR experiment at the European Spallation Source. (14th June 2021)

Authors:
Addazi, A; Anderson, K; Ansell, S; Babu, K S; Barrow, J L; Baxter, D V; Bentley, P M; Berezhiani, Z; Bevilacqua, R; Biondi, R; Bohm, C; Brooijmans, G; Broussard, L J; Cedercäll, J; Crawford, C; Dev, P S B; DiJulio, D D; Dolgov, A D; Dunne, K; Fierlinger, P
Journal:
Journal of physics
Issue:
Volume 48:Number 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P186 Impact of tofacitinib maintenance therapy on key Ulcerative Colitis patient-reported outcomes of fatigue, urgency, abdominal pain and sexual dysfunction using IBDQ and SF-36 individual items as proxies. (30th January 2023)

Authors:
Dubinsky, M C; Gardiner, S; Hur, P; Guo, X; Paulissen, J; Cappelleri, J C; Bushmakin, A G; Panés, J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i339
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P286 Sustained improvement in health-related quality of life outcomes in patients with Ulcerative Colitis with long-term tofacitinib treatment in the open-label extension study, OCTAVE Open. (21st January 2022)

Authors:
Biedermann, L; Dubinsky, M C; Vermeire, S; Fellmann, M; Gardiner, S; Hur, P; Mundayat, R; Panés, J; Rubin, D T
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P336 Association between the prior duration of remission and efficacy outcomes in patients with Ulcerative Colitis treated with tofacitinib 10 mg twice daily who were in stable remission and either dose-reduced to tofacitinib 5 mg twice daily or remained on 10 mg twice daily: 6-month data from the double-blind, randomised RIVETING study. (27th May 2021)

Authors:
Dubinsky, M C; D'Haens, G R; Sandborn, W J; Ng, S C; Panés, J; Su, C; Lawendy, N; Lazariciu, I; Gardiner, S; Mundayat, R; Kulisek, N; Modesto, I; Torres, J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S361
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P409 Non-invasive predictors of maintaining remission in patients with moderately to severely active Ulcerative Colitis treated with tofacitinib who dose-reduced from tofacitinib 10 mg twice daily to 5 mg twice daily: 6-month data from the double-blind, randomised RIVETING study. (27th May 2021)

Authors:
D'Haens, G R; Dubinsky, M C; Regueiro, M; Santana, G O; Torres, J; Kulisek, N; Gardiner, S; Mundayat, R; Paulissen, J; Lawendy, N; Su, C; Modesto, I; Sandborn, W J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S416
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P563 Association between smoking status and the efficacy and safety of tofacitinib in patients with Ulcerative Colitis: Data from the tofacitinib clinical programme. (21st January 2022)

Authors:
Rubin, D T; Torres, J; Regueiro, M; Reinisch, W; Prideaux, L; Kotze, P G; Tan, F H; Gardiner, S; Mundayat, R; Cadatal, M J; Ng, S C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i506
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗